The Mixed-mode Chromatography Resin Market covers resins that combine multiple purification techniques to efficiently separate biomolecules. These resins are widely used in biopharmaceuticals, including monoclonal antibodies and vaccines, driving demand for faster, cost-effective purification solutions.
According to FutureWise analysis, the mixed-mode chromatography resin market in 2026 is US$134.05 million and is expected to reach US$341.26 million by 2036 at a CAGR of 9.79%. The mixed-mode chromatography resin market is growing due to rising demand for advanced purification techniques in biopharmaceutical production, particularly for monoclonal antibodies and recombinant proteins. These resins provide enhanced selectivity, higher binding capacities, and fewer processing steps, making them well-suited for the separation of complex biomolecules. Moreover, the increasing emphasis on continuous bioprocessing and improved downstream efficiency is further driving the expansion of this market.
Growth Drivers:
- Rising demand for biopharmaceuticals like monoclonal antibodies and vaccines.
- Need for efficient and cost-effective purification processes in drug manufacturing.
- Advantages of faster processing with high selectivity and yield.
- Increasing adoption in research and clinical labs for complex biomolecule separation.
- Growing focus on quality and regulatory compliance in pharmaceutical production.
Key Trends:
- Growing adoption of mixed-mode resins for efficient biologics purification.
- Advancements in resin technology for better capacity and selectivity.
- Rise of single-use chromatography systems for flexibility and safety.
- Automation and process intensification in biomanufacturing.
- Expansion into personalized medicine and viral vector purification.
Market Segmentation and Key Players:
The Mixed-Mode Chromatography Resin Market is categorized by type into Ion Exchange-Hydrophobic, Hydroxyapatite, and other variations. It is also classified by application, including antibody production, vaccine production, non-antibody protein production, antibody-drug conjugate production, and the separation of low-molecular-weight impurities. Additionally, the market is divided by region into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Comprehensive segmentation details are provided in the Segmentation section below.
Major companies operating in the Mixed-mode Chromatography Resin Market include GE Healthcare Lifesciences and Merck.KGaA.
Research Methodology:
The research methodology for the Mixed-mode Chromatography Resin Market by FutureWise Research combines primary and secondary research. Primary research consists of interviews with industry experts and end-users, while secondary research includes company reports and industry databases. Market sizing and forecasts utilize top-down and bottom-up approaches, analyzing trends across types, applications, and regions. The study highlights market drivers, challenges, and key players like GE Healthcare Lifesciences and Merck KGaA, providing actionable insights for stakeholders.